%PDF-1.4
%
86 0 obj
<>
endobj
83 0 obj
<>
endobj
138 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2005-02-28T18:50:45Z
2024-03-28T19:10:03-07:00
QuarkXPressª: AdobePS 8.8.0 (301)
2024-03-28T19:10:03-07:00
application/pdf
Heather
2003-923.may
uuid:30a21303-1dd2-11b2-0a00-c208275dc400
uuid:30a21305-1dd2-11b2-0a00-810000000000
endstream
endobj
72 0 obj
<>
endobj
73 0 obj
<>
endobj
87 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 56 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 58 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 60 0 R/Type/Page>>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 62 0 R/Type/Page>>
endobj
26 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 64 0 R/Type/Page>>
endobj
45 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 66 0 R/Type/Page>>
endobj
160 0 obj
[164 0 R]
endobj
161 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
13.5 787.5 585 -783 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 61 736.1941 Tm
[(8.)-875.1 (Niermann KJ, Olsen NJ, Park JH. Magnesium abnormalities of)]TJ
1.675 -1.25 Td
(skeletal muscle in dermatomyositis and juvenile dermatomyositis.)Tj
0 -1.25 TD
(Arthritis Rheum 2002;46:475-88.)Tj
-1.675 -1.25 Td
[(9.)-875.1 (Park JH, Niermann KJ, R)39.7 (yder NM, et al. Muscle abnormalities in)]TJ
1.675 -1.25 Td
(juvenile dermatomyositis patients: P-31 magnetic resonance )Tj
T*
[(spectroscopy studies. )54.8 (Arthritis Rheum 2000;43:2359-67.)]TJ
-2.175 -1.25 Td
[(10.)-875.1 (Pfleiderer B, Lange J, Loske K, Sunderkotter C. Metabolic )]TJ
2.175 -1.25 Td
(disturbances during short exercises in dermatomyositis revealed by)Tj
T*
[(real-time functional 31P)-238.2 (magnetic resonance spectrometry)64.8 (.)]TJ
T*
(Rheumatology Oxford 2004;43:696-703.)Tj
-2.1381 -1.25 Td
[(1)36.8 (1)-0.1 (.)-875.1 (Bailey RC, Olson J, Pepper SL, Porszasz J, Barstow )17.7 (TJ, Cooper)]TJ
2.1381 -1.25 Td
[(DM. )17.7 (The level and tempo of children\325)54.8 (s physical activities: an)]TJ
T*
[(observational study)64.8 (. Med Sci Sports Exerc 1995;27:1033-41.)]TJ
-2.175 -1.25 Td
[(12.)-875.1 (T)69.9 (akken )17.7 (T)74 (, van der Net J, Helders PJ. Relationship between )]TJ
2.175 -1.25 Td
(functional ability and physical fitness in juvenile idiopathic arthritis\
)Tj
T*
(patients. Scand J Rheumatol 2003;32:174-8.)Tj
-2.175 -1.25 Td
[(13.)-875.1 (Bar)19.7 (-Or O. )17.7 (The )17.7 (W)39.8 (ingate anaerobic test. )54.8 (An update on methodology)64.8 (,)]TJ
2.175 -1.25 Td
[(reliability and validity)64.8 (. Sports Med 1987;4:381-94.)]TJ
-2.175 -1.25 Td
[(14.)-875.1 (T)35 (irosh E, Bar)19.7 (-Or O, Rosenbaum P)110.7 (. New muscle power test in )]TJ
2.175 -1.25 Td
[(neuromuscular disease. Feasibility and reliability)64.8 (. )54.8 (Am J Dis Child)]TJ
0 Tc 0 Tw T*
(1990;144:1083-7.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(15.)-875.1 (Malleson PN, Bennett SM, MacKinnon M, et al. Physical fitness)]TJ
2.175 -1.25 Td
(and its relationship to other indices of health status in children with)Tj
T*
(chronic arthritis. J Rheumatol 1996;23:1059-65.)Tj
-2.175 -1.25 Td
[(16.)-875.1 (Inbar O, Bar)19.7 (-Or O, Skinner JS. )17.7 (The )17.7 (W)39.8 (ingate anaerobic test.)]TJ
2.175 -1.25 Td
(Champaign, IL: Human Kinetics; 1996.)Tj
-2.175 -1.25 Td
[(17.)-875.1 (T)69.9 (akken )17.7 (T)74 (, van der Net J, Helders PJM. )54.8 (Anaerobic exercise capacity)]TJ
2.175 -1.25 Td
(in juvenile-onset idiopathic inflammatory myositis patients.)Tj
T*
(Arthritis Rheum 2005; \(in press\).)Tj
-2.175 -1.25 Td
[(18.)-875.1 (Bohan )54.8 (A, Peter JB. Polymyositis and dermatomyositis \(second of 2)]TJ
2.175 -1.25 Td
(parts\). N Engl J Med 1975;292:403-7.)Tj
-2.175 -1.25 Td
[(19.)-875.1 (Pollack ML, Schmidt DH, Jackson )54.8 (AS. Measurement of )]TJ
2.175 -1.25 Td
(cardio-respiratory fitness and body composition in the clinical )Tj
T*
[(setting. Compr )17.7 (Ther 1980;6:12-27.)]TJ
30.825 41.25 Td
[(20.)-875.1 (Latin R)54.8 (W)91.9 (. Surface anatomy)64.8 (. In: Roitman JL, editor)54.8 (. )54.8 (ACSM\325)54.9 (s)]TJ
2.175 -1.25 Td
(resource manual for guidelines for exercise testing and prescription.)Tj
T*
[(3rd ed. Baltimore: )17.7 (W)39.8 (illiams and )17.7 (W)39.9 (ilkins; 1998:89-100.)]TJ
-2.175 -1.25 Td
[(21.)-875.1 (Lode. )17.7 (W)39.8 (ingate software. )17.7 (V)110.8 (ersion 1.09 for DOS. Groningen: Lode)]TJ
0 Tc 2.175 -1.25 Td
[(BV)74 (; 1999.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(22.)-875.1 (Portney LG, )17.7 (W)79.9 (atkins MP)110.7 (. Foundations of clinical research: )]TJ
2.175 -1.25 Td
[(applications to practice. 2nd ed. Upper Saddle River)39.7 (, NJ: Prentice)]TJ
T*
(Hall; 2000.)Tj
-2.175 -1.25 Td
[(23.)-875.1 (Bland JM, )54.8 (Altman DG. Statistical methods for assessing agreement)]TJ
2.175 -1.25 Td
(between two methods of clinical measurement. Lancet )Tj
0 Tc 0 Tw T*
(1986;1:307-10.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(24.)-875.1 (Hopkins )17.7 (WG. Measures of reliability in sports medicine and )]TJ
2.175 -1.25 Td
(science. Sports Med 2000;30:1-15.)Tj
-2.175 -1.25 Td
[(25.)-875.1 (Knapp )17.7 (TR. )17.7 (T)69.9 (echnical error of measurement: a methodological )]TJ
-0.0298 Tw 2.175 -1.25 Td
[(critique. Am )-54.9 (J )-54.8 (Phys Anthropol1992;87:235-6.)]TJ
0.02499 Tw -2.175 -1.25 Td
[(26.)-875.1 (T)69.9 (akken )17.7 (T)74 (, van der Net J, Helders PJM. )54.8 (Aerobic exercise testing in)]TJ
2.175 -1.25 Td
(juvenile rheumatoid arthritis patients. Clin Exerc Physiol)Tj
0 Tc 0 Tw T*
(2002;4:38-43.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(27.)-875.1 (Giannini MJ, Protas EJ. Exercise response in children with and)]TJ
2.175 -1.25 Td
[(without juvenile rheumatoid arthritis: a case-comparison study)64.8 (.)]TJ
0.00729 Tw T*
[(Phys Ther )-17.7 (1992;72:365-72.)]TJ
0.02499 Tw -2.175 -1.25 Td
[(28.)-875.1 (Gore CJ. Quality assurance in exercise physiology laboratories. In:)]TJ
2.175 -1.25 Td
[(Gore CJ, editor)54.8 (. Physiological tests for elite athletes. Champaign,)]TJ
T*
[(IL: Human Kinetics; 2000:3-1)36.8 (1.)]TJ
-2.175 -1.25 Td
[(29.)-875.1 (Boileau RA, Bonen )54.8 (A, Heyward )17.7 (VH, Massey BH. Maximal aerobic)]TJ
2.175 -1.25 Td
[(capacity on the treadmill and bicycle er)17.7 (gometer of boys 1)36.8 (1-14 years)]TJ
T*
(of age. J Sports Med Physical Fitness 1977;17:153-62.)Tj
-2.175 -1.25 Td
[(30.)-875.1 (LeMura LM, von Duvillard SP)110.7 (, Cohen SL, et al. )17.7 (T)35 (readmill and)]TJ
2.175 -1.25 Td
[(cycle er)17.7 (gometry testing in 5- to 6-year)19.7 (-old children. Eur J )54.8 (Appl)]TJ
T*
(Physiol 2001;85:472-8.)Tj
-2.175 -1.25 Td
[(31.)-875.1 (Shvartz E, Reibold RC. )54.8 (Aerobic fitness norms for males and)]TJ
2.175 -1.25 Td
[(females aged 6 to 75 years: a review)64.8 (. )54.8 (A)74 (viat Space Environ Med)]TJ
0 Tw T*
[(1990;61:3-1)36.8 (1.)]TJ
ET
0 0 0 1 K
53.468 76.5 m
558.468 76.5 l
S
0 0 0 0 k
494.29 69.365 64.178 -15.665 re
f*
BT
0 0 0 1 k
/T1_1 1 Tf
0 Tc 8 0 0 8 545.468 56.4344 Tm
(739)Tj
ET
0 0 0 0 k
53.532 70.507 203 -16.856 re
f*
BT
0 0 0 1 k
/T1_1 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 54.532 56.3854 Tm
[(T)91.8 (akken, et al: Exer)36.8 (cise tolerance in juvenile DM)]TJ
ET
0 0 0 0 k
/GS0 gs
103.631 81.583 407.5 -10.833 re
f*
0.5 w
/GS1 gs
103.631 81.583 407.5 -10.833 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_2 8 Tf
108.828 74 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2005. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_3 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
66 0 obj
<>stream
8;Z\7MiPY.%.jN!@".9\>9,).$3N#)3lO2aUJ2`k;.eDS:B8[af^Zn*nb5%-*^:[g
E3)7?3W\rA5Os`9&r$Y&JF6+/5
U7`(O7u^M>+/BCC4o-fd]=Z?=AoP.EJOJK;+G4%OqI?q4Wf3c1"nb.+M,g>SXLqZ,
K*s=HQ+rj2SdKe[P+Bl!/Kc7*on\H)XY]$c6#Ol&IUib;;smV9%UqM)8iBfN:2(
Ht.2>:u)I#G$\X/#2#r4gSVS)$Z`e^6G"D#ihTXNgH=jM^JTA,-H:WWs0a1:$B_<#
!R(K,dA*N54Q*Ip97$*'fb>9=0ka`e=81(j]!?'VSO%-b`4nA5.>6$2<:l\#l%CUe
+oYLuQ_H,#:+m\)q?*CM7^69g48">-G^d*W5&u6BANbD52YF9%@C>9f;Znh==5uTj
pt,Ot1`D?CUX]Rd2M\)#r\9/iDj)tj?T^3OJ[n1t'>=&@Z~>
endstream
endobj
70 0 obj
[/Indexed/DeviceRGB 255 69 0 R]
endobj
69 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
101 0 obj
<>
endobj
89 0 obj
<>
endobj
125 0 obj
<>
endobj
143 0 obj
<>
endobj
90 0 obj
<>
endobj
116 0 obj
<>stream
HtUkPWa6Hv(]5>|0(00 ;11(#!">huqE,>R&$ɡj1UuN:~s+#L6:"4|)Q$9`q6Q7+jG&u9o$8~-UAru[YwzQ>>jɔ큁A33LRqBPYS{om
B
:au9Ud'LFI&!Bp3LiY
&m.Ik!dCjQ'Dp東f}^k̿c'd \d'b1"491CN&9MJ#I{q藽#%4)WCyss?YCP(^()_v6uq>bjXUqe䖑R}YzNgDŽi~Ʊ_
*Aeޜn롷cuK/*-m$.085 A20p
abUDڣ'Ǣۄ^oިT @uy2LޮnA-rϖل% rhO4PKI0R*! ˸u͵-'SII&]WT5އ @m~$:JNz78c'>8&R՚ CtOhQnwj8́XCTT#oe
%S`Q;gtX;7pc,_}|p!?--YgtwVIvQvAq٘A`AnXiZ ǫW{Xn$3FA